Section(X) | Body System(W) | Operation(0) | Approach(X) | Qualifier(5) | Device / Substance / Technology(V) | Body Part(D) |
New Technology | Anatomical Regions | Introduction | External | New Technology Group 5 | COVID-19 Vaccine Dose 3 | Mouth and Pharynx |
No record found
Change Type | Change Date | Previous Descriptor |
Code Deleted | 09-30-2024 | Introduction of Gilteritinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5 |
Code Added | 10-01-2019 |